Fast-Tracked DNA-Based Therapeutic Cancer Vaccine to Be Given to Melanoma Patients in U.K.
Patients in England with advanced skin melanoma are receiving a “revolutionary” new therapeutic cancer vaccine in a National Health Service (NHS) clinical trial that is being used to fast-track the biological to licensure. The vaccine, iSCIB1+—also known as ImmunoBody—is a DNA-based treatment designed to boost the immune system’s ability to target and remember melanoma cells.1 […]